CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Flu season boosts Reckitt Benckiser share price and sales

By Jenny McCall

08:23, 26 October 2021

Shelves of cold and flu medicines.
Reckitt reported that nine of its ten largest brands are up double-digits on a two-year basis – Photo: Shutterstock

Reckitt Benckiser, a British multinational consumer goods company headquartered in Slough, England, stock price surged on Tuesday as it reported strong growth in its quarter-three trading update.

The health, hygiene and nutrition consumer products manufacturer share price rose by over 5% to £57.78 as it posted group like-for-like (LFL) net revenue growth of 3.3%.

Reckitt said its sales high was driven by the return of the flu season. However, the consumer goods company said it was too early to say if the trajectory would continue.

“Additionally, whilst early season demand for our cold and flu relief products has been encouraging, it is too early to predict the extent to which trends will continue,” the statement said.

AUD/USD

0.66 Price
+0.480% 1D Chg, %
Long position overnight fee -0.0076%
Short position overnight fee -0.0006%
Overnight fee time 21:00 (UTC)
Spread 0.00050

GBP/JPY

174.31 Price
+0.210% 1D Chg, %
Long position overnight fee 0.0085%
Short position overnight fee -0.0168%
Overnight fee time 21:00 (UTC)
Spread 0.090

GBP/USD

1.25 Price
-0.650% 1D Chg, %
Long position overnight fee -0.0061%
Short position overnight fee -0.0021%
Overnight fee time 21:00 (UTC)
Spread 0.00110

USD/JPY

139.99 Price
+0.820% 1D Chg, %
Long position overnight fee 0.0105%
Short position overnight fee -0.0188%
Overnight fee time 21:00 (UTC)
Spread 0.040

Sales heat up

Reckitt said it now expects LFL net revenue growth for FY 2021 to come in the range of 1-3%, mainly due to the strong results seen in Q3 but also assuming a softer performance in Q4 due to reduced Covid prevalence in the US, which will result in a decrease of Lysol disinfectant sales.

Commenting on these results, Laxman Narasimhan, CEO, said: “In September, we reiterated the building blocks which will see Reckitt return to mid-single digit revenue growth and mid 20s margins. There is more to be done, but todays results are testament to our progress, with 3.3% LFL revenue growth building on the 15.3% growth of Q3 2020.”

“Weve delivered growth in each of our three GBUs [global business units] and in each of our three geographic regions, with a balance of volume and price/mix across the portfolio. Nine of our ten largest brands are up double-digits on a two-year basis.”

Read more: Reckitt cleans up with positive trading update

Related topics

Rate this article

Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 535.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading